NASDAQ:TSHA

Market

Taysha Gene Therapies Inc [TSHA] Revenue clocked in at $8.10 million, up 155.28% YTD: What’s Next?

Brandon Evans

Taysha Gene Therapies Inc [NASDAQ: TSHA] traded at a low on 2025-10-16, posting a -4.87 loss after which it closed ...

Market

Taysha Gene Therapies Inc [TSHA] stock Initiated by BofA Securities analyst, price target now $8

Misty Lee

Taysha Gene Therapies Inc [NASDAQ: TSHA] plunged by -$0.12 during the normal trading session on Friday and reaching a high ...

Companies

Taysha Gene Therapies Inc [TSHA] is 53.62% higher this YTD. Is it still time to buy?

Misty Lee

Taysha Gene Therapies Inc [NASDAQ: TSHA] loss -2.75% or -0.09 points to close at $3.18 with a heavy trading volume ...

Companies

why Taysha Gene Therapies Inc [TSHA] is a Good Choice for Investors After New Price Target of $8.67

Edison Baldwin

Taysha Gene Therapies Inc [NASDAQ: TSHA] stock went on an upward path that rose over 7.88% on Wednesday, amounting to ...

DBT News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.